All news about EDITAS MEDICINE, INC.
Analyst Recommendations on EDITAS MEDICINE, INC.
Sales 2022
17,1 M
–
–
Net income 2022
-222 M
–
–
Net cash 2022
361 M
–
–
P/E ratio 2022
-3,43x
Yield 2022
–
Capitalization
741 M
741 M
–
EV / Sales 2022
22,2x
EV / Sales 2023
24,5x
Nbr of Employees
264
Free-Float
99,5%
Chart EDITAS MEDICINE, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends EDITAS MEDICINE, INC.
Short Term
Mid-Term
Long Term
Trends
Neutral
Neutral
Bearish
Income Statement Evolution
Please enable JavaScript in your browser’s settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
11,01 $
Average target price
18,47 $
Spread / Average Target
67,7%
Please enable JavaScript in your browser’s settings to use dynamic charts.
[ad_2]